(Q35800752)

10 August 2017

Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma (English)

1 reference

10 August 2017

phase I clinical trial

0 references

1 reference

20

Henry S Friedman

1 reference

10 August 2017

11

Darell D Bigner

1 reference

10 August 2017

7

Sridharan Gururangan

1 reference

10 August 2017

3

Allan H Friedman

1 reference

10 August 2017

2

David A Reardon

1 reference

10 August 2017

4

Jeremy N Rich

1 reference

10 August 2017

1

Jennifer A Quinn

1 reference

10 August 2017

6

James Vredenburgh

1 reference

10 August 2017

13

James E Herndon

1 reference

10 August 2017

8

James M Provenzale

1 reference

10 August 2017

12

Sandra Tourt-Uhlig

1 reference

10 August 2017

14

Mary Lou Affronti

1 reference

10 August 2017

15

Susanne Jackson

1 reference

10 August 2017

18

Cindy Bohlin

1 reference

10 August 2017

John H Sampson

5

1 reference

10 August 2017

Amy Walker

9

1 reference

10 August 2017

Holly Schweitzer

10

1 reference

10 August 2017

Deborah Allen

16

1 reference

10 August 2017

Karen Ziegler

17

1 reference

10 August 2017

Christy Lentz

19

1 reference

10 August 2017

1 April 2004

1 reference

10 August 2017

1 reference

10 August 2017

6

1 reference

10 August 2017

2

1 reference

10 August 2017

145-153

1 reference

Altered irinotecan metabolism in a patient receiving phenytoin

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

The current status of camptothecin analogues as antitumor agents

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

The basis for current treatment recommendations for malignant gliomas

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

Therapy of adult malignant brain tumors: what have the clinical trials taught us?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

Irinotecan therapy in adults with recurrent or progressive malignant glioma.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871988

10.1215/S1152851703000498

25 September 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference